L. Utilizing the New FDA Label: Prescribing in Pregnancy, Lactation, and Reproductive Age Populations

19th Annual NPWH Premier Women's Healthcare Conference

1.25 CE, 1.25 Rx (NCC Code 4)

Patricia Geraghty, MSN, FNP-BC, WHNP

This presentation introduces the new FDA labeling format for prescribing in pregnancy and discusses how it will be implemented. Because the previous ABCDX format will be phased out gradually, both formats will be reviewed. Specific examples of challenges in evaluating data to determine safety in practice; evidence-based management of specific conditions common to the pregnant or lactating populations and of pregnancy related conditions; and strategy and general guidelines for prescribing in pregnancy and lactation will be covered.

Presentations